Happy Monday. It’s Lizzie here in New York. Today we’re looking at a potential thaw in 2022’s chilly IPO markets, while Spirit Airlines rebuffs an unsolicited bid from JetBlue and another health-care deal percolates in Europe.
Today’s top stories
- Spirit Airlines
rejects JetBlue bid, sticks with Frontier.
- Finance’s glitterati, dealmakers and celebrities are
at Milken .
- Astorg Partners
nears 2.5 billion-euro deal for CordenPharma.
IPO thaw
After a months-long drought in the U.S. IPO market, there’s finally some signs of life. Contact lens maker Bausch + Lomb is